These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3252981)

  • 21. Antibody response to oral polio vaccine in premature infants.
    Smolen P; Bland R; Heiligenstein E; Lawless MR; Dillard R; Abramson J
    J Pediatr; 1983 Dec; 103(6):917-9. PubMed ID: 6644426
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
    Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
    Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipoliomyelitis program in Brazil; a erologic study of immunity levels.
    de Brito Bastos NC; Carvalho Filho ES de+CARVALHOAAFILHO ES; Schatzmayr H; Homma A; Chaves J
    Bull Pan Am Health Organ; 1974; 8(1):54-65. PubMed ID: 4423450
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunoprophylaxis in poliomyelitis.
    John TJ
    J Commun Dis; 1984 Mar; 16(1):38-42. PubMed ID: 12055784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Behaviour and properties of poliomyelitis coproantibodies using the "antiglobin test" and the conventional neutralisation test (author's transl)].
    Albano A; De Donato S; Scarinci V; Jakschik M
    Zentralbl Bakteriol Orig A; 1974 Feb; 226(1):1-11. PubMed ID: 4152333
    [No Abstract]   [Full Text] [Related]  

  • 26. [Poliomyelitis vaccination in Denmark].
    Petersen I
    Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neutralizing antibodies to poliovirus in the sera of newborn infants before and after mass immunization of the Brazilian population from 0 to 5. São Paulo, Brazil (1980)].
    Hutzler RU; Fujita M; Waldman EA; Ayub MA; Ferrari FL; Pinto PR; Cury PC; Kim JS; Matheus JG
    Rev Inst Med Trop Sao Paulo; 1984; 26(2):78-82. PubMed ID: 6089300
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polio eradication in India: pulse polio immunization.
    Sokhey J
    Indian Pediatr; 1996 Mar; 33(3):254-6. PubMed ID: 8772857
    [No Abstract]   [Full Text] [Related]  

  • 30. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunity of children and adolescents to poliomyelitis before and after type 3 oral vaccination, and immunity of unvaccinated infants in the Olsztyn Province].
    Rodkiewicz T; Weglińska T
    Przegl Epidemiol; 1972; 26(2):201-4. PubMed ID: 5070976
    [No Abstract]   [Full Text] [Related]  

  • 32. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A checking-up survey of 2 counties of north part of Guangdong Province concerning the eradication of poliomyelitis].
    Li J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1987 Feb; 8(1):37-9. PubMed ID: 3621318
    [No Abstract]   [Full Text] [Related]  

  • 35. [Post-vaccination anti-poliomyelitis seroprevalence in an urban setting in Abidjan].
    Akoua-Koffi G; Thonnon J; Kouassi-Renaud M; Dosso M; Ehouman A
    Bull Soc Pathol Exot; 1995; 88(3):117-20. PubMed ID: 8555765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity to poliomyelitis.
    Schoub BD; Johnson S; McAnerney JM
    Lancet; 1990 Jul; 336(8707):126. PubMed ID: 1975315
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
    Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
    Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of the Sabin vaccine in malnourished children of the Amazonian region].
    Stewien KE; Shrimpton R; da Cunha LC; Alvim MA; Viana LF; Marinho HA; da Costa CA
    Rev Saude Publica; 1985 Feb; 19(1):51-7. PubMed ID: 3001923
    [No Abstract]   [Full Text] [Related]  

  • 39. Poliomyelitis vaccines: an appraisal after 25 years.
    Melnick JL
    Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Antibodies to poliovirus.
    MacLeod DR
    Can Med Assoc J; 1976 May; 114(9):754-6. PubMed ID: 1268785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.